Inventor
BOUT ABRAHAM
NL55 patents
⚠️ This page may combine multiple inventors who share the name “BOUT ABRAHAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRUCELL HOLLAND BV
29 patentsUS7270811B2Sep 18, 2007
Serotype of adenovirus and uses thereof
CRUCELL HOLLAND BV112 citations98
US7429486B2Sep 30, 2008
Recombinant production of mixtures of antibodies
CRUCELL HOLLAND BV82 citations97
US7262028B2Aug 28, 2007
Recombinant production of mixtures of antibodies
CRUCELL HOLLAND BV245 citations97
US6913922B1Jul 5, 2005
Serotype of adenovirus and uses thereof
CRUCELL HOLLAND BV86 citations97
US6855544B1Feb 15, 2005
Recombinant protein production in a human cell
CRUCELL HOLLAND BV96 citations96
US7820440B2Oct 26, 2010
Means and methods for producing adenovirus vectors
CRUCELL HOLLAND BV20 citations93
US7468181B2Dec 23, 2008
Means and methods for the production of adenovirus vectors
CRUCELL HOLLAND BV25 citations93
US6670188B1Dec 30, 2003
Packaging systems for human recombinant adenovirus to be used in gene therapy
CRUCELL HOLLAND BV25 citations93
US7906113B2Mar 15, 2011
Serotype of adenovirus and uses thereof
CRUCELL HOLLAND BV19 citations92
US7749493B2Jul 6, 2010
Chimeric adenoviruses
CRUCELL HOLLAND BV19 citations92
US6905678B2Jun 14, 2005
Gene delivery vectors with cell type specificity for mesenchymal stem cells
CRUCELL HOLLAND BV32 citations92
US6869936B1Mar 22, 2005
Means and methods for fibroblast-like or macrophage-like cell transduction
CRUCELL HOLLAND BV19 citations91
US7491532B2Feb 17, 2009
Recombinant protein production in a human cell
CRUCELL HOLLAND BV17 citations90
US7132280B2Nov 7, 2006
Recombinant protein production in a human cell
CRUCELL HOLLAND BV14 citations90
US7470523B2Dec 30, 2008
Recombinant protein production in a human cell
CRUCELL HOLLAND BV12 citations88
US7304031B2Dec 4, 2007
Methods and means for producing proteins with predetermined post-translational modifications
CRUCELL HOLLAND BV13 citations88
US7235233B2Jun 26, 2007
Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
CRUCELL HOLLAND BV11 citations84
US6803234B2Oct 12, 2004
Gene delivery vectors with cell type specificity for primary human chondrocytes
CRUCELL HOLLAND BV13 citations84
US6929946B1Aug 16, 2005
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
CRUCELL HOLLAND BV12 citations83
US7037716B2May 2, 2006
Packaging systems for human recombinant adenovirus to be used in gene therapy
CRUCELL HOLLAND BV5 citations74
US7105346B2Sep 12, 2006
Packaging systems for human recombinant adenovirus to be used in gene therapy
CRUCELL HOLLAND BV4 citations72
US6783980B2Aug 31, 2004
Packaging systems for human recombinant adenovirus to be used in gene therapy
CRUCELL HOLLAND BV6 citations72
US6692966B2Feb 17, 2004
Packaging systems for human recombinant adenovirus to be used in gene therapy
CRUCELL HOLLAND BV10 citations72
US7696157B2Apr 13, 2010
Methods and means for producing proteins with predetermined post-translational modifications
CRUCELL HOLLAND BV4 citations68
US6495131B1Dec 17, 2002
Interleukin-3 gene therapy for cancer
CRUCELL HOLLAND BV6 citations63
US7968087B2Jun 28, 2011
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
CRUCELL HOLLAND BV3 citations62
US7238528B2Jul 3, 2007
Means and methods for fibroblast-like or macrophage-like cell transduction
CRUCELL HOLLAND BV5 citations62
US7052881B2May 30, 2006
Packaging systems for human recombinant adenovirus to be used in gene therapy
CRUCELL HOLLAND BV2 citations61
US7785833B2Aug 31, 2010
Methods and means for producing proteins with predetermined post-translational modifications
CRUCELL HOLLAND BV2 citations57
INTROGENE BV
10 patentsUS6878549B1Apr 12, 2005
Packaging systems for human recombinant adenovirus to be used in gene therapy
INTROGENE BV67 citations98
US6033908AMar 7, 2000
Packaging systems for human recombinant adenovirus to be used in gene therapy
INTROGENE BV362 citations98
US5994128ANov 30, 1999
Packaging systems for human recombinant adenovirus to be used in gene therapy
INTROGENE BV539 citations97
US6395519B1May 28, 2002
Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
INTROGENE BV34 citations94
US6306652B1Oct 23, 2001
Packaging systems for human recombinant adenovirus to be used in gene therapy
INTROGENE BV73 citations94
US6265212B1Jul 24, 2001
Packaging systems for human recombinant adenovirus to be used in gene therapy
INTROGENE BV55 citations94
US6238893B1May 29, 2001
Method for intracellular DNA amplification
INTROGENE BV20 citations92
US6602706B1Aug 5, 2003
Packaging systems for human recombinant adenovirus to be used in gene therapy
INTROGENE BV22 citations91
US6204052B1Mar 20, 2001
Adenoviral vectors with reduced TNF response and partial E3 region deletion
INTROGENE BV37 citations89
US6303300B1Oct 16, 2001
Poly (organo) phosphazenes for use in synthetic transfection systems
INTROGENE BV1 citations52
MERUS B V
2 patentsGALAPAGOS GENOMICS NV
2 patentsUS6340595B1Jan 22, 2002
High throughput screening of gene function using adenoviral libraries for functional genomics applications
GALAPAGOS GENOMICS NV59 citations93
US7029848B2Apr 18, 2006
High throughput screening of gene function using libraries for functional genomics applications
GALAPAGOS GENOMICS NV37 citations89
MERUS NV
2 patentsUNIVERSITEIT UTRECHT INTROGENE
1 patentGALAPAGOS GEONOMICS N V
1 patentVAN BERKEL PATRICIUS H C
1 patentFALLAUX FRITS J
1 patentBOUT ABRAHAM
1 patentShowing the top 50 of 55 patents by PatentIndex Score.